SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. ROIV
5. ORCL
6. QCOM
7. IONS
8. AAPL
9. HOOD
10. TTAN

Go back to SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
(NASDAQ: SPRC) Delayed: 5.10 --0 (-0%)
Previous Close $5.10    52 Week High $ 
Open $5.10    52 Week Low $ 
Day High $5.10    P/E N/A 
Day Low $5.10    EPS $ 
Volume 4       

(NASDAQ: SPRC) Delayed: 5.10 --0 (-0%)
Previous Close $5.10    52 Week High $ 
Open $5.10    52 Week Low $ 
Day High $5.10    P/E N/A 
Day Low $5.10    EPS $ 
Volume 4